Výsledky vyhledávání - "Erick Crespo-Solís"

Prognostic Factors, Response to Treatment, and Survival in Patients With Chronic Myeloid Leukemia in Blast Phase: A Single-Institution Survey

Autor: Fernando Pérez-Jacobo, Erick Crespo-Solís, Alvaro Aguayo, Elena Tuna-Aguilar, Xavier López-Karpovitch, Roberta Demichelis-Gómez, Ubaldo Rafael Valencia-Rocha

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 15:778-784

Data from 51 patients (23 women) with chronic myeloid leukemia (CML) in blast phase (BP) were analyzed in order to identify prognostic factors for complete hematologic response (CHR) and survival.Forty-four patients experienced disease progression fr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2110815101169e8c07bafef594fc6445
https://doi.org/10.1016/j.clml.2015.09.007

Zobrazit plný text záznamu

Diagnosis of Acute Leukemia in Cerebrospinal Fluid (CSF-Acute Leukemia)

Autor: Xavier López-Karpovitch, Jesús Higuera, Erick Crespo-Solís, Beatriz Vega-Ramos

Publikováno v: Current Oncology Reports. 14:369-378

Cerebrospinal fluid-acute leukemia (CSF-acute leukemia) is a frequent and serious complication in patients with acute leukemia. One of the major problems of this complication is the diagnosis process itself. CSF cytology is currently considered the g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdbaf14106ccce140d4c08e7f31cb005
https://doi.org/10.1007/s11912-012-0248-6

Zobrazit plný text záznamu

Outcomes of Substituting Oral Fludarabine for Intravenous Fludarabine in Combination with Cytarabine and Filgrastim for Treatment of Primary Refractory or Relapsed Acute Leukemias

Autor: Roberta, Demichelis-Gómez, Erick, Crespo-Solís, Luis Fernando, Pérez-Jacobo, Ubaldo Rafael, Valencia-Rocha, Adriana, Rosas-López

Publikováno v: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 67(5)

Treatment of relapsed/refractory acute myeloid or lymphoid leukemia consists of salvage chemotherapy followed by allogeneic hematopoietic stem-cell transplantation. Intravenous fludarabine, cytarabine, and filgrastim is an effective regimen in this s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3c0425d6854b63f78bd9f91c08112067
https://pubmed.ncbi.nlm.nih.gov/26696332

Zobrazit plný text záznamu

Thalidomide and Dexamethasone Induction Therapy Until Best Response in Recently Diagnosed Patients with Multiple Myeloma: Results From a Pilot Study

Autor: Lauro Fabián, Amador-Medina, Dennis, Lacayo-Leñero, Erick, Crespo-Solís, Álvaro, Aguayo, Déborah, Martínez-Baños

Publikováno v: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 67(5)

Novel therapies for multiple myeloma are not affordable for all healthcare systems.The objectives of this study were to evaluate the response rates, overall survival, event-free survival, and toxicity of thalidomide and dexamethasone administered unt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::66856fb19630be10318c3202e135899e
https://pubmed.ncbi.nlm.nih.gov/26696334

Zobrazit plný text záznamu

Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy

Autor: Gabriela Anaya-Saavedra, Imelda González-Ramírez, Esther Irigoyen Camacho, Sergio Ponce-de-León, Velia Ramírez-Amador, Erick Crespo-Solís

Publikováno v: Supportive Care in Cancer. 18:639-646

Knowledge of oral mucositis (OM) in patients with acute leukemia (AL) and chemotherapy (CT) has remained limited. Thus, a prospective, longitudinal study was undertaken to characterize clinical features, associated risk factors, and behavior of OM in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e81f7cebf3ced9b725b861d85d6cc3e
https://doi.org/10.1007/s00520-009-0708-1

Zobrazit plný text záznamu

Chronic Myeloid Leukemia: A Clinicoepidemiologic and Therapeutic Description of a Single Institution in Mexico City

Autor: Yael Cazares-Ordonez, Elizabeth Guadarrama-Beltran, Erick Crespo-Solís, Alvaro Aguayo, Xavier López-Karpovitch, Eduardo E. Cervera-Ceballos, Eunice Garcia-Alvarez, Deborah Martinez-Baños

Publikováno v: Clinical Leukemia. 2:261-266

Background: Chronic myeloid leukemia (CML) is a malignant disease caused by the protein coded by the Philadelphia chromosome. Imatinib mesylate (IM) is now the treatment of choice for all stages of CML. Clinicoepidemiologic information on CML from de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ad39a1aa3426cc0b789659d8ed7e7ad8
https://doi.org/10.3816/clk.2008.n.036

Zobrazit plný text záznamu

Multidrug Resistance-1 in T Lymphocytes and Natural Killer Cells of Adults with Idiopathic Thrombocytopenic Purpura: Effect of Prednisone Treatment

Autor: Xavier López-Karpovitch, Gerardo Graue, Erick Crespo-Solís, Josefa Piedras

Publikováno v: Archives of Medical Research. 39:541-545

High P-glycoprotein-mediated multidrug resistance-1 (P-gp/MDR1) activity in lymphocytes from idiopathic thrombocytopenic purpura (ITP) patients may affect disease outcome. ITP treatment includes glucocorticoids that are substrates of P-gp; hence, P-g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e3400fa4228ade086df644528c64145
https://doi.org/10.1016/j.arcmed.2008.04.004

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání